

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.74340367 |
| 2 | vocalization behavior (GO:0071625) | 5.28401221 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.27581525 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.22896507 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.14611138 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.98167193 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.94982336 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.92406004 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.90918816 |
| 10 | protein localization to synapse (GO:0035418) | 4.82036519 |
| 11 | glutamate secretion (GO:0014047) | 4.80047138 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.68454191 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.65898880 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.61951679 |
| 15 | behavioral response to nicotine (GO:0035095) | 4.57913863 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.48921181 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.45832632 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.44317959 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.30977731 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 4.26545502 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.23845505 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.15511063 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.13329396 |
| 24 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.08696497 |
| 25 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.05401791 |
| 26 | cellular potassium ion homeostasis (GO:0030007) | 3.97742609 |
| 27 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.96713094 |
| 28 | exploration behavior (GO:0035640) | 3.90100697 |
| 29 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.89135613 |
| 30 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.84129824 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.83102092 |
| 32 | response to pheromone (GO:0019236) | 3.81552884 |
| 33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.80235179 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 3.75211029 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.71199573 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.70937279 |
| 37 | long-term memory (GO:0007616) | 3.69016135 |
| 38 | synaptic vesicle endocytosis (GO:0048488) | 3.65136544 |
| 39 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.64958190 |
| 40 | neurotransmitter transport (GO:0006836) | 3.64572940 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.61678752 |
| 42 | presynaptic membrane assembly (GO:0097105) | 3.60409492 |
| 43 | proline transport (GO:0015824) | 3.59730657 |
| 44 | positive regulation of membrane potential (GO:0045838) | 3.59032868 |
| 45 | neuron recognition (GO:0008038) | 3.56848875 |
| 46 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.56407895 |
| 47 | regulation of synapse structural plasticity (GO:0051823) | 3.55201395 |
| 48 | transmission of nerve impulse (GO:0019226) | 3.53204587 |
| 49 | gamma-aminobutyric acid transport (GO:0015812) | 3.51952638 |
| 50 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.51641087 |
| 51 | response to histamine (GO:0034776) | 3.49504018 |
| 52 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.48257939 |
| 53 | postsynaptic membrane organization (GO:0001941) | 3.47379995 |
| 54 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.46911590 |
| 55 | long-term synaptic potentiation (GO:0060291) | 3.46541314 |
| 56 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.45991916 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.45265239 |
| 58 | layer formation in cerebral cortex (GO:0021819) | 3.43269148 |
| 59 | dendritic spine morphogenesis (GO:0060997) | 3.42930134 |
| 60 | innervation (GO:0060384) | 3.41348962 |
| 61 | cerebellar granule cell differentiation (GO:0021707) | 3.39723209 |
| 62 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.38765890 |
| 63 | neuromuscular process controlling posture (GO:0050884) | 3.38658523 |
| 64 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.37568943 |
| 65 | membrane hyperpolarization (GO:0060081) | 3.36329269 |
| 66 | epithelial cilium movement (GO:0003351) | 3.34451826 |
| 67 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.33350405 |
| 68 | presynaptic membrane organization (GO:0097090) | 3.32193360 |
| 69 | mating behavior (GO:0007617) | 3.32082018 |
| 70 | nucleobase catabolic process (GO:0046113) | 3.31119198 |
| 71 | membrane depolarization during action potential (GO:0086010) | 3.29292930 |
| 72 | synapse assembly (GO:0007416) | 3.28005830 |
| 73 | regulation of vesicle fusion (GO:0031338) | 3.25708940 |
| 74 | protein polyglutamylation (GO:0018095) | 3.25086609 |
| 75 | regulation of synaptic plasticity (GO:0048167) | 3.24122923 |
| 76 | nonmotile primary cilium assembly (GO:0035058) | 3.23497848 |
| 77 | axonal fasciculation (GO:0007413) | 3.23459526 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 3.22673862 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.22516053 |
| 80 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.20514839 |
| 81 | membrane depolarization (GO:0051899) | 3.18345641 |
| 82 | regulation of synapse maturation (GO:0090128) | 3.15711023 |
| 83 | sodium ion export (GO:0071436) | 3.13152612 |
| 84 | behavioral fear response (GO:0001662) | 3.12871333 |
| 85 | behavioral defense response (GO:0002209) | 3.12871333 |
| 86 | prepulse inhibition (GO:0060134) | 3.11119890 |
| 87 | striatum development (GO:0021756) | 3.10467914 |
| 88 | axoneme assembly (GO:0035082) | 3.08926464 |
| 89 | positive regulation of neurotransmitter transport (GO:0051590) | 3.08216069 |
| 90 | response to auditory stimulus (GO:0010996) | 3.05095039 |
| 91 | fear response (GO:0042596) | 3.03505226 |
| 92 | learning (GO:0007612) | 3.03127975 |
| 93 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.02556045 |
| 94 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.02485720 |
| 95 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.02056657 |
| 96 | * synaptic transmission (GO:0007268) | 3.01928568 |
| 97 | activation of protein kinase A activity (GO:0034199) | 3.00136276 |
| 98 | startle response (GO:0001964) | 3.00074684 |
| 99 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.99831468 |
| 100 | regulation of respiratory system process (GO:0044065) | 2.98802615 |
| 101 | dendrite morphogenesis (GO:0048813) | 2.97951564 |
| 102 | adult walking behavior (GO:0007628) | 2.97603855 |
| 103 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.97560477 |
| 104 | neuronal action potential (GO:0019228) | 2.97448911 |
| 105 | somite development (GO:0061053) | 2.97142090 |
| 106 | neuronal ion channel clustering (GO:0045161) | 2.97012546 |
| 107 | behavioral response to cocaine (GO:0048148) | 2.96385030 |
| 108 | neuromuscular process controlling balance (GO:0050885) | 2.95819797 |
| 109 | auditory behavior (GO:0031223) | 2.95691534 |
| 110 | positive regulation of synapse assembly (GO:0051965) | 2.95675404 |
| 111 | positive regulation of synaptic transmission (GO:0050806) | 2.93301181 |
| 112 | serotonin metabolic process (GO:0042428) | 2.91529558 |
| 113 | reflex (GO:0060004) | 2.90696834 |
| 114 | long term synaptic depression (GO:0060292) | 2.89490452 |
| 115 | protein localization to cilium (GO:0061512) | 2.88037610 |
| 116 | glycerophospholipid catabolic process (GO:0046475) | 2.83717910 |
| 117 | cilium movement (GO:0003341) | 2.83659643 |
| 118 | regulation of cilium movement (GO:0003352) | 2.82046137 |
| 119 | regulation of action potential (GO:0098900) | 2.81394628 |
| 120 | regulation of neurotransmitter uptake (GO:0051580) | 2.75369660 |
| 121 | mechanosensory behavior (GO:0007638) | 2.74566914 |
| 122 | primary amino compound metabolic process (GO:1901160) | 2.71769155 |
| 123 | retinal cone cell development (GO:0046549) | 2.69564616 |
| 124 | fucose catabolic process (GO:0019317) | 2.67456283 |
| 125 | L-fucose metabolic process (GO:0042354) | 2.67456283 |
| 126 | L-fucose catabolic process (GO:0042355) | 2.67456283 |
| 127 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.64981231 |
| 128 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.64170838 |
| 129 | detection of light stimulus involved in visual perception (GO:0050908) | 2.64170838 |
| 130 | inositol phosphate catabolic process (GO:0071545) | 2.63456561 |
| 131 | retinal ganglion cell axon guidance (GO:0031290) | 2.62507283 |
| 132 | dopamine transport (GO:0015872) | 2.61441681 |
| 133 | glycosphingolipid biosynthetic process (GO:0006688) | 2.61388903 |
| 134 | action potential (GO:0001508) | 2.58988074 |
| 135 | protein complex biogenesis (GO:0070271) | 2.57307287 |
| 136 | central nervous system myelination (GO:0022010) | 2.55109929 |
| 137 | axon ensheathment in central nervous system (GO:0032291) | 2.55109929 |
| 138 | cell proliferation in forebrain (GO:0021846) | 2.53428780 |
| 139 | photoreceptor cell development (GO:0042461) | 2.53348162 |
| 140 | neural tube formation (GO:0001841) | 2.52131425 |
| 141 | establishment of protein localization to Golgi (GO:0072600) | 2.52077809 |
| 142 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.51188693 |
| 143 | cilium organization (GO:0044782) | 2.50141177 |
| 144 | multicellular organismal signaling (GO:0035637) | 2.50005953 |
| 145 | spinal cord development (GO:0021510) | 2.48976858 |
| 146 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.47767063 |
| 147 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.47767063 |
| 148 | dentate gyrus development (GO:0021542) | 2.47037954 |
| 149 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.46639189 |
| 150 | cilium assembly (GO:0042384) | 2.46523951 |
| 151 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.45937740 |
| 152 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.44861286 |
| 153 | adaptation of signaling pathway (GO:0023058) | 2.44485176 |
| 154 | cilium morphogenesis (GO:0060271) | 2.44332970 |
| 155 | brain morphogenesis (GO:0048854) | 2.42985484 |
| 156 | photoreceptor cell maintenance (GO:0045494) | 2.42783853 |
| 157 | intraciliary transport (GO:0042073) | 2.42518392 |
| 158 | C4-dicarboxylate transport (GO:0015740) | 2.41024497 |
| 159 | indolalkylamine metabolic process (GO:0006586) | 2.39424297 |
| 160 | spinal cord motor neuron differentiation (GO:0021522) | 2.39269308 |
| 161 | neuromuscular synaptic transmission (GO:0007274) | 2.37902957 |
| 162 | neuron fate determination (GO:0048664) | 2.37235764 |
| 163 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.37166863 |
| 164 | NADH dehydrogenase complex assembly (GO:0010257) | 2.37166863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.61019783 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.99074831 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04338712 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.94186588 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93489539 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.71527006 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55560234 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55560234 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54029521 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52257503 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.49390330 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47993989 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36363933 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34926031 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34174820 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30632036 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.28262766 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.26486740 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17181990 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.14838409 |
| 21 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14776822 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12605111 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12047445 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.12012427 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.05827767 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99950281 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.97631431 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97407934 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95528441 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.87798550 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86289997 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.85981330 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.85112231 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83031728 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.82235615 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82099765 |
| 37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.71635664 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70447560 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67132162 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62764056 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.61562441 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59502885 |
| 43 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.57751607 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.56052305 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51699303 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49756313 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.46609240 |
| 48 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.45260511 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44493504 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44428959 |
| 51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42826382 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42494022 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40817277 |
| 54 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.39620586 |
| 55 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39149870 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39149870 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39027557 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38668549 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.37205388 |
| 60 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37105846 |
| 61 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36124374 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34707265 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34376815 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33513523 |
| 65 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31901961 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31757488 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29902377 |
| 68 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28645618 |
| 69 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27839683 |
| 70 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.26579665 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26348838 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25775581 |
| 73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25330735 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22981741 |
| 75 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21456759 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.21384584 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19999457 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19765244 |
| 79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19661372 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19302193 |
| 81 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17292007 |
| 82 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.17100593 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.16485198 |
| 84 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15913106 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15013658 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14203394 |
| 87 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14150361 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14107386 |
| 89 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.13478924 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12614825 |
| 91 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12569264 |
| 92 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.12543978 |
| 93 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.12304590 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11856819 |
| 95 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.11562523 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11429244 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10594315 |
| 98 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09921592 |
| 99 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08811199 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08523723 |
| 101 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08523723 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07818304 |
| 103 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07279988 |
| 104 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07007806 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05971754 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05628613 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05355628 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05115771 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04276184 |
| 110 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04255196 |
| 111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04230415 |
| 112 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04230415 |
| 113 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04042477 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02543205 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99139809 |
| 116 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98747327 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98667636 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97226939 |
| 119 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96787879 |
| 120 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96450810 |
| 121 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96082388 |
| 122 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94974317 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94971290 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94666782 |
| 125 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92907782 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92323271 |
| 127 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92040981 |
| 128 | JUN_21703547_ChIP-Seq_K562_Human | 0.91113658 |
| 129 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90690098 |
| 130 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87693967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.39830532 |
| 2 | MP0003880_abnormal_central_pattern | 4.61216792 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.80573877 |
| 4 | MP0009046_muscle_twitch | 3.28080471 |
| 5 | MP0004270_analgesia | 3.21605406 |
| 6 | MP0009745_abnormal_behavioral_response | 3.21180483 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.06950348 |
| 8 | MP0002064_seizures | 3.02445275 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.98379157 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.75488082 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.72274280 |
| 12 | MP0002272_abnormal_nervous_system | 2.66165288 |
| 13 | MP0001486_abnormal_startle_reflex | 2.60367079 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.59649206 |
| 15 | MP0002102_abnormal_ear_morphology | 2.49669986 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.36667383 |
| 17 | MP0002736_abnormal_nociception_after | 2.35638042 |
| 18 | MP0002822_catalepsy | 2.26290799 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.21122525 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.15587696 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.10483080 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 2.06599403 |
| 23 | MP0001984_abnormal_olfaction | 2.01613313 |
| 24 | MP0002184_abnormal_innervation | 1.96541042 |
| 25 | MP0006276_abnormal_autonomic_nervous | 1.95533491 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.89499037 |
| 27 | MP0001970_abnormal_pain_threshold | 1.87562208 |
| 28 | MP0000778_abnormal_nervous_system | 1.85253854 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.78918519 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.77259316 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.77160408 |
| 32 | MP0004924_abnormal_behavior | 1.77160408 |
| 33 | MP0008569_lethality_at_weaning | 1.75227728 |
| 34 | MP0001188_hyperpigmentation | 1.72880231 |
| 35 | MP0003787_abnormal_imprinting | 1.72119072 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.70382622 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.67582990 |
| 38 | MP0001529_abnormal_vocalization | 1.66358726 |
| 39 | MP0003646_muscle_fatigue | 1.58783730 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.58594903 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.58204871 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.56947300 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.50788580 |
| 44 | MP0000955_abnormal_spinal_cord | 1.50540036 |
| 45 | MP0004133_heterotaxia | 1.47334787 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.46940364 |
| 47 | MP0003122_maternal_imprinting | 1.46150916 |
| 48 | MP0003879_abnormal_hair_cell | 1.44869797 |
| 49 | MP0003195_calcinosis | 1.44191742 |
| 50 | MP0004858_abnormal_nervous_system | 1.43779615 |
| 51 | MP0004742_abnormal_vestibular_system | 1.41490817 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.36459280 |
| 53 | MP0003011_delayed_dark_adaptation | 1.35717638 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.34870736 |
| 55 | MP0003329_amyloid_beta_deposits | 1.34205118 |
| 56 | MP0004142_abnormal_muscle_tone | 1.30571942 |
| 57 | MP0001905_abnormal_dopamine_level | 1.30137387 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.30071811 |
| 59 | MP0004885_abnormal_endolymph | 1.25787468 |
| 60 | MP0002229_neurodegeneration | 1.25728315 |
| 61 | MP0002090_abnormal_vision | 1.22730565 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.22484714 |
| 63 | MP0005253_abnormal_eye_physiology | 1.21781297 |
| 64 | MP0003633_abnormal_nervous_system | 1.17991713 |
| 65 | MP0005379_endocrine/exocrine_gland_phen | 1.12662264 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 1.11813735 |
| 67 | MP0002152_abnormal_brain_morphology | 1.09992149 |
| 68 | MP0005499_abnormal_olfactory_system | 1.09262983 |
| 69 | MP0005394_taste/olfaction_phenotype | 1.09262983 |
| 70 | MP0006292_abnormal_olfactory_placode | 1.07300200 |
| 71 | MP0002163_abnormal_gland_morphology | 1.05975048 |
| 72 | MP0002752_abnormal_somatic_nervous | 1.05643871 |
| 73 | MP0002938_white_spotting | 1.05137558 |
| 74 | MP0003631_nervous_system_phenotype | 1.03844503 |
| 75 | MP0000013_abnormal_adipose_tissue | 1.03063578 |
| 76 | MP0001963_abnormal_hearing_physiology | 1.01798776 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 1.01653311 |
| 78 | MP0003136_yellow_coat_color | 0.99551004 |
| 79 | MP0000049_abnormal_middle_ear | 0.98908885 |
| 80 | MP0000427_abnormal_hair_cycle | 0.95883813 |
| 81 | MP0008872_abnormal_physiological_respon | 0.93462811 |
| 82 | MP0003119_abnormal_digestive_system | 0.91360894 |
| 83 | MP0002069_abnormal_eating/drinking_beha | 0.90717604 |
| 84 | MP0003634_abnormal_glial_cell | 0.90042025 |
| 85 | MP0003890_abnormal_embryonic-extraembry | 0.89460408 |
| 86 | MP0002751_abnormal_autonomic_nervous | 0.89346275 |
| 87 | MP0008995_early_reproductive_senescence | 0.88892964 |
| 88 | MP0000751_myopathy | 0.86384567 |
| 89 | MP0002928_abnormal_bile_duct | 0.85223307 |
| 90 | MP0000372_irregular_coat_pigmentation | 0.85003075 |
| 91 | MP0003938_abnormal_ear_development | 0.84982296 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.84458644 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.82983336 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.82701695 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.81911355 |
| 96 | MP0003632_abnormal_nervous_system | 0.81674016 |
| 97 | MP0002160_abnormal_reproductive_system | 0.80824572 |
| 98 | MP0004043_abnormal_pH_regulation | 0.80778525 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.80415347 |
| 100 | MP0003878_abnormal_ear_physiology | 0.80415347 |
| 101 | MP0005409_darkened_coat_color | 0.79756748 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.79439494 |
| 103 | MP0005535_abnormal_body_temperature | 0.76326433 |
| 104 | MP0004215_abnormal_myocardial_fiber | 0.75527120 |
| 105 | MP0004085_abnormal_heartbeat | 0.75359625 |
| 106 | MP0004233_abnormal_muscle_weight | 0.74723808 |
| 107 | MP0002653_abnormal_ependyma_morphology | 0.74650844 |
| 108 | MP0005195_abnormal_posterior_eye | 0.73648951 |
| 109 | MP0003283_abnormal_digestive_organ | 0.72663492 |
| 110 | MP0001177_atelectasis | 0.71438931 |
| 111 | MP0002837_dystrophic_cardiac_calcinosis | 0.67001237 |
| 112 | MP0008874_decreased_physiological_sensi | 0.65305869 |
| 113 | MP0001986_abnormal_taste_sensitivity | 0.65120381 |
| 114 | MP0003121_genomic_imprinting | 0.64775843 |
| 115 | MP0000026_abnormal_inner_ear | 0.64008701 |
| 116 | MP0000920_abnormal_myelination | 0.63115978 |
| 117 | MP0001664_abnormal_digestion | 0.62772730 |
| 118 | MP0003690_abnormal_glial_cell | 0.60590876 |
| 119 | MP0003137_abnormal_impulse_conducting | 0.59078488 |
| 120 | MP0003861_abnormal_nervous_system | 0.57755202 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.57734598 |
| 122 | MP0008789_abnormal_olfactory_epithelium | 0.57701154 |
| 123 | MP0008877_abnormal_DNA_methylation | 0.55665590 |
| 124 | MP0005171_absent_coat_pigmentation | 0.55462409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.20230113 |
| 2 | Myokymia (HP:0002411) | 5.61875882 |
| 3 | Focal seizures (HP:0007359) | 5.27774245 |
| 4 | Febrile seizures (HP:0002373) | 5.18108456 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.98740698 |
| 6 | Atonic seizures (HP:0010819) | 4.91376675 |
| 7 | Visual hallucinations (HP:0002367) | 4.71772355 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.57863114 |
| 9 | Absence seizures (HP:0002121) | 4.43077281 |
| 10 | Dialeptic seizures (HP:0011146) | 4.05596107 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.81556604 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.74545562 |
| 13 | Pancreatic cysts (HP:0001737) | 3.68880745 |
| 14 | Action tremor (HP:0002345) | 3.57071241 |
| 15 | True hermaphroditism (HP:0010459) | 3.53330493 |
| 16 | Nephronophthisis (HP:0000090) | 3.53235100 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.45761689 |
| 18 | Broad-based gait (HP:0002136) | 3.44095314 |
| 19 | Congenital stationary night blindness (HP:0007642) | 3.36460448 |
| 20 | Hyperventilation (HP:0002883) | 3.33699492 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 3.33114314 |
| 22 | Abnormality of midbrain morphology (HP:0002418) | 3.33114314 |
| 23 | Dysdiadochokinesis (HP:0002075) | 3.20544870 |
| 24 | Truncal ataxia (HP:0002078) | 3.16609826 |
| 25 | Central scotoma (HP:0000603) | 3.13515514 |
| 26 | Abnormality of the renal medulla (HP:0100957) | 2.94922443 |
| 27 | Drooling (HP:0002307) | 2.90172799 |
| 28 | Excessive salivation (HP:0003781) | 2.90172799 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 2.89953976 |
| 30 | Poor eye contact (HP:0000817) | 2.85168174 |
| 31 | Methylmalonic acidemia (HP:0002912) | 2.84310301 |
| 32 | Depression (HP:0000716) | 2.80915448 |
| 33 | Abnormality of macular pigmentation (HP:0008002) | 2.76720667 |
| 34 | Dysmetria (HP:0001310) | 2.75481286 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.75331183 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.72844821 |
| 37 | Ankle clonus (HP:0011448) | 2.72607364 |
| 38 | Gait imbalance (HP:0002141) | 2.71438387 |
| 39 | Pendular nystagmus (HP:0012043) | 2.67591045 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.65435873 |
| 41 | Anxiety (HP:0000739) | 2.64374225 |
| 42 | Abnormality of the renal cortex (HP:0011035) | 2.63055576 |
| 43 | Hemiparesis (HP:0001269) | 2.63050248 |
| 44 | Mutism (HP:0002300) | 2.60264530 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.59266760 |
| 46 | Impaired social interactions (HP:0000735) | 2.57858915 |
| 47 | Abnormal social behavior (HP:0012433) | 2.57858915 |
| 48 | Epileptiform EEG discharges (HP:0011182) | 2.56322574 |
| 49 | Type II lissencephaly (HP:0007260) | 2.55613865 |
| 50 | Amblyopia (HP:0000646) | 2.55189680 |
| 51 | Abolished electroretinogram (ERG) (HP:0000550) | 2.54423187 |
| 52 | Limb dystonia (HP:0002451) | 2.53893161 |
| 53 | Genetic anticipation (HP:0003743) | 2.49684422 |
| 54 | Fetal akinesia sequence (HP:0001989) | 2.46012906 |
| 55 | Pheochromocytoma (HP:0002666) | 2.45063117 |
| 56 | Scanning speech (HP:0002168) | 2.44500664 |
| 57 | Absent speech (HP:0001344) | 2.44186974 |
| 58 | Congenital primary aphakia (HP:0007707) | 2.42524389 |
| 59 | EEG with generalized epileptiform discharges (HP:0011198) | 2.41869863 |
| 60 | Progressive inability to walk (HP:0002505) | 2.41774204 |
| 61 | Cystic liver disease (HP:0006706) | 2.41097647 |
| 62 | Postural instability (HP:0002172) | 2.39295828 |
| 63 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.35341985 |
| 64 | Spastic gait (HP:0002064) | 2.33242716 |
| 65 | Optic nerve hypoplasia (HP:0000609) | 2.30091232 |
| 66 | Methylmalonic aciduria (HP:0012120) | 2.30090545 |
| 67 | Renal cortical cysts (HP:0000803) | 2.26349037 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.24769878 |
| 69 | Medial flaring of the eyebrow (HP:0010747) | 2.23728076 |
| 70 | Scotoma (HP:0000575) | 2.21324597 |
| 71 | Abnormality of the corticospinal tract (HP:0002492) | 2.21129003 |
| 72 | Polyphagia (HP:0002591) | 2.20313005 |
| 73 | Abnormality of binocular vision (HP:0011514) | 2.19836026 |
| 74 | Diplopia (HP:0000651) | 2.19836026 |
| 75 | Hypsarrhythmia (HP:0002521) | 2.16939821 |
| 76 | Acute necrotizing encephalopathy (HP:0006965) | 2.16827067 |
| 77 | Chronic hepatic failure (HP:0100626) | 2.14508990 |
| 78 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.14364047 |
| 79 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.14364047 |
| 80 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.14341007 |
| 81 | Insidious onset (HP:0003587) | 2.14041489 |
| 82 | Termporal pattern (HP:0011008) | 2.14041489 |
| 83 | Intestinal atresia (HP:0011100) | 2.13118333 |
| 84 | Progressive macrocephaly (HP:0004481) | 2.12858199 |
| 85 | Abnormality of the labia minora (HP:0012880) | 2.12122785 |
| 86 | Status epilepticus (HP:0002133) | 2.11444404 |
| 87 | Agitation (HP:0000713) | 2.11090273 |
| 88 | Specific learning disability (HP:0001328) | 2.10692165 |
| 89 | Neuroendocrine neoplasm (HP:0100634) | 2.09818094 |
| 90 | Lissencephaly (HP:0001339) | 2.08196383 |
| 91 | Attenuation of retinal blood vessels (HP:0007843) | 2.07911527 |
| 92 | Bradykinesia (HP:0002067) | 2.06692782 |
| 93 | Dysmetric saccades (HP:0000641) | 2.06387655 |
| 94 | Sclerocornea (HP:0000647) | 2.05622382 |
| 95 | Inability to walk (HP:0002540) | 2.04433005 |
| 96 | Abnormality of the lower motor neuron (HP:0002366) | 2.04022519 |
| 97 | Stereotypic behavior (HP:0000733) | 2.02650040 |
| 98 | Intention tremor (HP:0002080) | 2.01628755 |
| 99 | Septo-optic dysplasia (HP:0100842) | 2.01149444 |
| 100 | Genital tract atresia (HP:0001827) | 1.99970272 |
| 101 | Urinary urgency (HP:0000012) | 1.99366880 |
| 102 | Hypothermia (HP:0002045) | 1.99197849 |
| 103 | Polydipsia (HP:0001959) | 1.98334897 |
| 104 | Abnormal drinking behavior (HP:0030082) | 1.98334897 |
| 105 | Protruding tongue (HP:0010808) | 1.97710390 |
| 106 | Abnormal ciliary motility (HP:0012262) | 1.97425965 |
| 107 | Poor coordination (HP:0002370) | 1.97133847 |
| 108 | Pachygyria (HP:0001302) | 1.96997918 |
| 109 | Hemiplegia (HP:0002301) | 1.96996260 |
| 110 | Abnormality of salivation (HP:0100755) | 1.96618099 |
| 111 | Oligodactyly (hands) (HP:0001180) | 1.96563738 |
| 112 | Torticollis (HP:0000473) | 1.96397261 |
| 113 | Vaginal atresia (HP:0000148) | 1.95184877 |
| 114 | Retinal dysplasia (HP:0007973) | 1.93739399 |
| 115 | Male pseudohermaphroditism (HP:0000037) | 1.92351570 |
| 116 | Anencephaly (HP:0002323) | 1.92072130 |
| 117 | Blue irides (HP:0000635) | 1.91598747 |
| 118 | Congenital hepatic fibrosis (HP:0002612) | 1.90396604 |
| 119 | Neurofibrillary tangles (HP:0002185) | 1.90101730 |
| 120 | Generalized myoclonic seizures (HP:0002123) | 1.89500817 |
| 121 | Impaired vibratory sensation (HP:0002495) | 1.89140629 |
| 122 | Thyroid-stimulating hormone excess (HP:0002925) | 1.88474864 |
| 123 | Hyperglycinemia (HP:0002154) | 1.88470292 |
| 124 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.88341741 |
| 125 | Dyschromatopsia (HP:0007641) | 1.88266762 |
| 126 | Gait ataxia (HP:0002066) | 1.88226208 |
| 127 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.87903188 |
| 128 | Postaxial foot polydactyly (HP:0001830) | 1.87858291 |
| 129 | Decreased central vision (HP:0007663) | 1.87441739 |
| 130 | Postaxial hand polydactyly (HP:0001162) | 1.87416427 |
| 131 | Absent/shortened dynein arms (HP:0200106) | 1.87199033 |
| 132 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87199033 |
| 133 | Severe visual impairment (HP:0001141) | 1.87119033 |
| 134 | Lower limb muscle weakness (HP:0007340) | 1.86673271 |
| 135 | Incomplete penetrance (HP:0003829) | 1.84057607 |
| 136 | Increased corneal curvature (HP:0100692) | 1.84003134 |
| 137 | Keratoconus (HP:0000563) | 1.84003134 |
| 138 | Mitochondrial inheritance (HP:0001427) | 1.83765728 |
| 139 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.83722811 |
| 140 | Cerebral inclusion bodies (HP:0100314) | 1.83433713 |
| 141 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82774237 |
| 142 | Abnormality of vitamin B metabolism (HP:0004340) | 1.82293932 |
| 143 | Failure to thrive in infancy (HP:0001531) | 1.81934926 |
| 144 | Furrowed tongue (HP:0000221) | 1.81402434 |
| 145 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.80594367 |
| 146 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.80594367 |
| 147 | Hypoventilation (HP:0002791) | 1.79551723 |
| 148 | Colon cancer (HP:0003003) | 1.79457357 |
| 149 | Focal dystonia (HP:0004373) | 1.78930332 |
| 150 | Large for gestational age (HP:0001520) | 1.78556319 |
| 151 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.78392582 |
| 152 | Acute encephalopathy (HP:0006846) | 1.77538966 |
| 153 | Horizontal nystagmus (HP:0000666) | 1.77214603 |
| 154 | Ventricular fibrillation (HP:0001663) | 1.76850755 |
| 155 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.76622874 |
| 156 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.70613311 |
| 157 | Tubular atrophy (HP:0000092) | 1.70240312 |
| 158 | Hypomagnesemia (HP:0002917) | 1.67583996 |
| 159 | Dyskinesia (HP:0100660) | 1.67529141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.86511674 |
| 2 | NTRK3 | 4.55540028 |
| 3 | EPHA4 | 3.83776868 |
| 4 | MAP3K4 | 3.50516784 |
| 5 | CASK | 3.13031583 |
| 6 | MAP3K9 | 3.01017234 |
| 7 | MAP2K7 | 2.96827504 |
| 8 | MARK1 | 2.91249526 |
| 9 | MAP4K2 | 2.65710774 |
| 10 | MINK1 | 2.56738112 |
| 11 | GRK1 | 2.33860696 |
| 12 | PAK6 | 2.18586350 |
| 13 | NTRK2 | 2.08250271 |
| 14 | DAPK2 | 2.04277798 |
| 15 | PRPF4B | 1.94046335 |
| 16 | MAP2K4 | 1.91767887 |
| 17 | ADRBK2 | 1.88154179 |
| 18 | MAP3K12 | 1.87211285 |
| 19 | BMPR1B | 1.85052065 |
| 20 | TNIK | 1.81332086 |
| 21 | PLK2 | 1.58732250 |
| 22 | MAPK13 | 1.57594453 |
| 23 | PNCK | 1.56703125 |
| 24 | KSR2 | 1.50263325 |
| 25 | RIPK4 | 1.50092379 |
| 26 | GRK5 | 1.49187823 |
| 27 | CDK19 | 1.44260125 |
| 28 | CDK5 | 1.44071621 |
| 29 | KSR1 | 1.42533588 |
| 30 | NTRK1 | 1.41588239 |
| 31 | FGFR2 | 1.38170805 |
| 32 | DAPK1 | 1.37476299 |
| 33 | DYRK2 | 1.36915860 |
| 34 | TAOK3 | 1.36906416 |
| 35 | PRKD3 | 1.36742896 |
| 36 | CAMKK1 | 1.36408147 |
| 37 | STK38 | 1.34822567 |
| 38 | NUAK1 | 1.29845063 |
| 39 | CAMKK2 | 1.29619560 |
| 40 | PRKCG | 1.25722113 |
| 41 | WNK4 | 1.22994757 |
| 42 | UHMK1 | 1.21209823 |
| 43 | CSNK1G1 | 1.18585966 |
| 44 | SGK494 | 1.13894169 |
| 45 | SGK223 | 1.13894169 |
| 46 | CSNK1G3 | 1.12786125 |
| 47 | CAMK2A | 1.12260059 |
| 48 | ACVR1B | 1.12193686 |
| 49 | AKT3 | 1.11877411 |
| 50 | SIK2 | 1.11251336 |
| 51 | STK16 | 1.08357393 |
| 52 | TLK1 | 1.07195506 |
| 53 | PHKG2 | 1.06437802 |
| 54 | PHKG1 | 1.06437802 |
| 55 | ARAF | 1.04326481 |
| 56 | CAMK2B | 1.02668138 |
| 57 | TRIM28 | 1.02646164 |
| 58 | OXSR1 | 1.02625098 |
| 59 | SGK2 | 0.99178543 |
| 60 | FES | 0.98490245 |
| 61 | ZAK | 0.95635620 |
| 62 | MKNK2 | 0.91100626 |
| 63 | ERBB3 | 0.90824158 |
| 64 | MAP3K2 | 0.90409498 |
| 65 | DYRK1A | 0.89434858 |
| 66 | STK38L | 0.89354706 |
| 67 | CDK18 | 0.88067043 |
| 68 | TXK | 0.86782322 |
| 69 | CDK15 | 0.85088151 |
| 70 | CDK14 | 0.84307932 |
| 71 | CAMK1 | 0.84246006 |
| 72 | CSNK1A1L | 0.81955840 |
| 73 | PINK1 | 0.81584286 |
| 74 | WNK3 | 0.81121181 |
| 75 | STK11 | 0.81087441 |
| 76 | INSRR | 0.78838441 |
| 77 | BCKDK | 0.76700833 |
| 78 | CAMK2D | 0.76181521 |
| 79 | WNK1 | 0.76079191 |
| 80 | BMPR2 | 0.74749257 |
| 81 | CDK11A | 0.73656698 |
| 82 | MAPK15 | 0.73139739 |
| 83 | SGK1 | 0.72432645 |
| 84 | STK39 | 0.71654779 |
| 85 | CSNK1G2 | 0.70849689 |
| 86 | PAK3 | 0.70388633 |
| 87 | MAP3K13 | 0.69709233 |
| 88 | SIK3 | 0.69500819 |
| 89 | TYRO3 | 0.68941434 |
| 90 | NEK6 | 0.67353461 |
| 91 | PRKCH | 0.66970678 |
| 92 | SGK3 | 0.65631498 |
| 93 | PRKCE | 0.64401734 |
| 94 | PKN1 | 0.63308998 |
| 95 | BCR | 0.61999193 |
| 96 | MAP3K6 | 0.61960809 |
| 97 | BRAF | 0.60984840 |
| 98 | TNK2 | 0.60842333 |
| 99 | LATS2 | 0.60602135 |
| 100 | IRAK2 | 0.60409690 |
| 101 | NME1 | 0.60180049 |
| 102 | RET | 0.59136280 |
| 103 | ALK | 0.57212400 |
| 104 | CAMK1G | 0.56188355 |
| 105 | CAMK2G | 0.55967546 |
| 106 | PTK2B | 0.55853342 |
| 107 | MARK2 | 0.55423991 |
| 108 | FER | 0.55273845 |
| 109 | CDK3 | 0.54835507 |
| 110 | CCNB1 | 0.54828966 |
| 111 | CSNK1A1 | 0.54174853 |
| 112 | GRK7 | 0.53297921 |
| 113 | MAPK10 | 0.50115927 |
| 114 | MAP2K6 | 0.49987396 |
| 115 | RPS6KA3 | 0.49313770 |
| 116 | EPHA3 | 0.47769164 |
| 117 | OBSCN | 0.46604202 |
| 118 | ADRBK1 | 0.46305598 |
| 119 | TIE1 | 0.46247814 |
| 120 | CDC42BPA | 0.44266471 |
| 121 | PRKAA1 | 0.44239384 |
| 122 | CSNK1D | 0.43920783 |
| 123 | PRKCZ | 0.43783937 |
| 124 | MAP3K1 | 0.42116741 |
| 125 | FGR | 0.41743803 |
| 126 | RAF1 | 0.40984463 |
| 127 | PRKG1 | 0.40411807 |
| 128 | ERBB2 | 0.40364456 |
| 129 | PDK1 | 0.40277978 |
| 130 | VRK1 | 0.40163503 |
| 131 | TAOK1 | 0.39603743 |
| 132 | PRKACA | 0.39410292 |
| 133 | DYRK3 | 0.38759359 |
| 134 | CAMK4 | 0.38737996 |
| 135 | PDPK1 | 0.38219186 |
| 136 | PRKCB | 0.37878614 |
| 137 | PRKCA | 0.37057059 |
| 138 | PRKCQ | 0.36091777 |
| 139 | PIK3CA | 0.34251122 |
| 140 | PRKACB | 0.31400259 |
| 141 | RPS6KA5 | 0.31315771 |
| 142 | TEC | 0.30595447 |
| 143 | RPS6KB1 | 0.30411821 |
| 144 | CSNK1E | 0.29684756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.31437379 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.49804570 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.94400485 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.91687339 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.70600982 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.68960982 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.65166411 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.64804062 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.49827729 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.44187302 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.41217935 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.25978652 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19870676 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.18893348 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 2.13308153 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.13082532 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 2.11296178 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 2.11169061 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08661431 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.01021637 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90145027 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88419860 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.82234860 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.79559201 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.76000827 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74017124 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73955489 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.72065525 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68511544 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.68459216 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.61748581 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58398003 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.54109134 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53606846 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.47602301 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37091699 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.34662346 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34425713 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33654248 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29243029 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27443803 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27278049 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26708493 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.24037093 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23826812 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 1.23426527 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.21382830 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20373691 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18733547 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17642395 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15252065 |
| 52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09380855 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07787721 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07506102 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06407375 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06118541 |
| 57 | Axon guidance_Homo sapiens_hsa04360 | 1.05989178 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.04732071 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03270687 |
| 60 | RNA degradation_Homo sapiens_hsa03018 | 1.00385099 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00284363 |
| 62 | RNA polymerase_Homo sapiens_hsa03020 | 0.93746425 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92250562 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.90628914 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89703149 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89414906 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.86112466 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84916771 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.83576541 |
| 70 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83163408 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82996566 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82677723 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81515657 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80024689 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78547059 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78521445 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76394879 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76261574 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75202183 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74913983 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74321632 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72625159 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71757515 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70121469 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70084575 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68968739 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68401070 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68376179 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67259652 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67004308 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.65782759 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65546392 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65323014 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.62383551 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58967326 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58620783 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58566438 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.57916405 |
| 99 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.57519654 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56213091 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55326365 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53641704 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53596215 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53368909 |
| 105 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52641981 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52559454 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51144801 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50646876 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49706274 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46224525 |
| 111 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44865346 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44721067 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43360101 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42010096 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41996617 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41994491 |
| 117 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41305114 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40204219 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39855046 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39733137 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39634786 |
| 122 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39244683 |
| 123 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38797700 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37959543 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.37363997 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37059695 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35510726 |
| 128 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.34756145 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34556511 |
| 130 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33902788 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32686012 |
| 132 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32421711 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32377090 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.31335206 |
| 135 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30724540 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30183720 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30063148 |
| 138 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29943180 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29590153 |
| 140 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29380942 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28590477 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.28068267 |
| 143 | Bile secretion_Homo sapiens_hsa04976 | 0.27992504 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24721929 |
| 145 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24338171 |
| 146 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24302194 |
| 147 | Mineral absorption_Homo sapiens_hsa04978 | 0.24214400 |

